CannabisNewsBreaks – Canna-V-Cell Sciences Inc. (CSE: CNVC) Achieves Significant Milestone in 16-Month Program
Canna-V-Cell Sciences (CSE: CNVC) ("CannaVcell") recently announced its achievement of a significant milestone of having cannabis trichomes at the suspension phase. According to the update, CannaVcell, on October 2018, embarked on a 16 months program to prove the feasibility of applying its unique Biofarming technology on cannabis. “This clearly confirms that the progress made to-date towards the completion of the 16 months development program has exceeded the expectations,” CannaVcell CTO Dr. Yochi Hagay said in the news release. “We can now be assured that the goals of the program will be achieved ahead of schedule.” To view the full press…

















